Your browser doesn't support javascript.
loading
Conditional survival in advanced colorectal cancer and surgery.
Wancata, Lauren M; Banerjee, Mousumi; Muenz, Daniel G; Haymart, Megan R; Wong, Sandra L.
Afiliação
  • Wancata LM; Department of Surgery, University of Michigan, North Campus Research Complex, Ann Arbor, Michigan.
  • Banerjee M; Department of Biostatistics, University of Michigan, Ann Arbor, Michigan.
  • Muenz DG; Department of Biostatistics, University of Michigan, Ann Arbor, Michigan.
  • Haymart MR; Department of Medicine, Division of Metabolism, Endocrinology & Diabetes & Hematology/Oncology, University of Michigan, North Campus Research Complex, Ann Arbor, Michigan.
  • Wong SL; Department of Surgery, Dartmouth-Hitchcock Medical Center, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire. Electronic address: sandra.l.wong@hitchcock.org.
J Surg Res ; 201(1): 196-201, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26850202
ABSTRACT

BACKGROUND:

Recent data show patients with advanced colorectal cancer (CRC) are surviving longer. What is unknown is how specific treatment modalities affect long-term survival. Conditional survival, or survival prognosis based on time already survived, is becoming an acceptable means of estimating prognosis for long-term survivors. We evaluated the impact of cancer-directed surgery on long-term survival in patients with advanced CRC.

METHODS:

We used Surveillance, Epidemiology, and End Results data to identify 64,956 patients with advanced (Stage IV) CRC diagnosed from 2000-2009. Conditional survival estimates by stage, age, and cancer-directed surgery were obtained based on Cox proportional hazards regression model of disease-specific survival.

RESULTS:

A total of 64,956 (20.1%) patients had advanced disease at the time of diagnosis. The proportion of those patients who underwent cancer-directed surgery was 65.1% (n = 42,176). Cancer-directed surgery for patients with advanced stage disease was associated with a significant improvement in traditional survival estimates compared to patients who did not undergo surgery (hazard ratio = 2.22 [95% confidence interval, 2.17-2.27]). Conditional survival estimates show improvement in conditional 5-y disease-specific survival across all age groups, demonstrating sustained survival benefits for selected patients with advanced CRC.

CONCLUSIONS:

Five-year disease-specific conditional survival improves dramatically over time for selected patients with advanced CRC who undergo cancer-directed surgery. This information is important in determining long-term prognosis and will help inform treatment planning for advanced CRC.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais Idioma: En Ano de publicação: 2016 Tipo de documento: Article